Can I give a muscle relaxant to an otherwise healthy adult with non‑fractured rib pain?

Muscle Relaxants for Non-Fractured Rib Pain

Yes, you can give a muscle relaxant for non-fractured rib pain in an otherwise healthy adult, but the evidence supporting this practice is weak and the choice of agent matters significantly. The most appropriate option is methocarbamol for short-term use (≤2 weeks), combined with acetaminophen or NSAIDs as first-line therapy. 1, 2

First-Line Therapy: Not Muscle Relaxants

• Acetaminophen (1000 mg every 6 hours IV or PO) should be your primary analgesic for acute musculoskeletal pain, including rib pain, as part of a multimodal approach. 3
• NSAIDs may be added for severe pain after assessing cardiovascular and gastrointestinal risk factors; use the lowest effective dose with gastroprotection in higher-risk patients. 3, 1
• Muscle relaxants should never be used as monotherapy—they must be combined with acetaminophen or NSAIDs and non-pharmacologic measures (ice, immobilization). 3, 1

When to Add a Muscle Relaxant

If acetaminophen and NSAIDs provide inadequate relief after 24–48 hours, consider adding a muscle relaxant for acute pain only (maximum 7–14 days). 1, 4

Preferred Agent: Methocarbamol

• Methocarbamol is the safest muscle relaxant for rib pain because it does not lower blood pressure, has minimal anticholinergic effects, and has demonstrated opioid-sparing efficacy in traumatic rib fractures. 5, 2
• In young adults with ≥3 rib fractures, methocarbamol reduced cumulative opioid consumption by 35% (219 vs 337 mg oral morphine equivalents, p=0.01) and shortened hospital length of stay (3 vs 4 days, p=0.03). 2
• Dose: 1500 mg PO four times daily or 1000 mg IV/IM every 8 hours for acute pain. 4
• Methocarbamol is less sedating than cyclobenzaprine but still doubles the risk of CNS adverse events (dizziness, drowsiness) compared with placebo (RR 2.04). 6

Alternative Agent: Cyclobenzaprine (With Major Caveats)

• Low-dose cyclobenzaprine (5 mg PO three times daily for ≤14 days) may be considered only in carefully selected patients without contraindications. 1
• Cyclobenzaprine has fair evidence for acute musculoskeletal pain relief at 2–4 days but is chemically related to amitriptyline and carries significant anticholinergic risks (urinary retention, blurred vision, dry mouth, constipation, cognitive impairment). 1, 7, 4
• Sedation occurs in >30% of patients, and CNS adverse events occur twice as frequently as placebo. 1
• Do not use in older adults (≥65 years) because of high fall risk, anticholinergic burden, and cognitive impairment. 1

Agents to Avoid

• Tizanidine must be avoided because its alpha-2-adrenergic agonist activity produces dose-dependent hypotension, which is inappropriate for musculoskeletal pain. 5
• Carisoprodol is contraindicated because it is a controlled substance with abuse potential, withdrawal risk, and limited analgesic benefit. 1, 5
• Baclofen should not be used for simple rib pain; it is reserved for true spasticity from upper-motor-neuron disorders (stroke, MS, spinal cord injury) and has sparse evidence for musculoskeletal pain. 7
• Benzodiazepines are not recommended for musculoskeletal pain because they offer no advantage over skeletal muscle relaxants, have abuse potential, and lack FDA approval for this indication. 5

Critical Pitfalls & Practical Considerations

Mechanism Misconception

• Muscle relaxants do not produce true skeletal muscle relaxation; their effect is nonspecific CNS depression via polysynaptic reflex inhibition, not peripheral muscle targeting. 5, 7
• Prescribing them with the expectation of directly relieving muscle spasm is unfounded. 1, 7

Duration Limitation

• Do not extend muscle relaxant therapy beyond 2 weeks; all efficacy trials evaluated only short-term use (≤14 days), and chronic use increases adverse events without proven benefit. 1, 5, 6
• Reassess pain and functional status after one week and discontinue if no clear benefit is observed. 1

Adverse Event Profile

• All skeletal muscle relaxants double the risk of CNS adverse events (RR 2.04), primarily sedation and dizziness. 5, 6
• Avoid concurrent use with benzodiazepines or opioids because of marked increases in sedation and respiratory depression risk. 5
• In older adults, muscle relaxants increase fall risk, emergency department visits, hospitalizations, and delirium. 1

Blood Pressure Considerations

• If the patient has hypotension or requires blood pressure stability, methocarbamol, chlorzoxazone, metaxalone, or cyclobenzaprine are safe options because they do not lower blood pressure. 5
• Never use tizanidine when blood pressure stability is required. 5

Evidence Strength & Nuances

• The evidence for muscle relaxants in non-fractured rib pain is extrapolated from acute low back pain trials and one small study in traumatic rib fractures. 2, 6
• A Cochrane review of 30 trials (n=2,454) found strong evidence that muscle relaxants are more effective than placebo for acute low back pain at 2–4 days (pooled RR 0.80 for pain relief), but adverse events were significantly more prevalent (RR 1.50). 6
• No trial has directly compared muscle relaxants to acetaminophen or NSAIDs for rib pain, and they have not been proven superior to these agents for low back pain. 4, 6
• The single study in rib fractures (n=50) was observational and retrospective, limiting causal inference, but showed clinically meaningful opioid reduction. 2

Monitoring & Follow-Up

• Assess pain intensity, functional status, and adverse effects at 3–5 days and again at 7 days. 1
• Discontinue the muscle relaxant if no improvement is observed by one week or if adverse effects outweigh benefits. 1
• Monitor for sedation, dizziness, fall risk, and anticholinergic effects (if using cyclobenzaprine). 1, 6